A Real-Time Clinical Decision Support System, for Mild Cognitive Impairment Detection, Based on a Hybrid Neural Architecture

Abstract

Clinical procedure for mild cognitive impairment (MCI) is mainly based on clinical records and short cognitive tests. However, low suspicion and difficulties in understanding test cut-offs make diagnostic accuracy being low, particularly in primary care. Artificial neural networks (ANNs) are suitable to design computed aided diagnostic systems because of their features of generating relationships between variables and their learning capability. The main aim pursued in that work is to explore the ability of a hybrid ANN-based system in order to provide a tool to assist in the clinical decision-making that facilitates a reliable MCI estimate. The model is designed to work with variables usually available in primary care, including Minimental Status Examination (MMSE), Functional Assessment Questionnaire (FAQ), Geriatric Depression Scale (GDS), age, and years of education. It will be useful in any clinical setting. Other important goal of our study is to compare the diagnostic rendering of ANN-based system and clinical physicians. A sample of 128 MCI subjects and 203 controls was selected from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). The ANN-based system found the optimal variable combination, being AUC, sensitivity, specificity, and clinical utility index (CUI) calculated. The ANN results were compared with those from medical experts which include two family physicians, a neurologist, and a geriatrician. The optimal ANN model reached an AUC of 95.2%, with a sensitivity of 90.0% and a specificity of 84.78% and was based on MMSE, FAQ, and age inputs. As a whole, physician performance achieved a sensitivity of 46.66% and a specificity of 91.3%. CUIs were also better for the ANN model. The proposed ANN system reaches excellent diagnostic accuracy although it is based only on common clinical tests. These results suggest that the system is especially suitable for primary care implementation, aiding physicians work with cognitive impairment suspicions.

Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer’s Disease Not Using Neuroimaging Biomarkers: A Systematic Review

“…Neuropsychological tests (some subscales of MMSE and its total score, a subtest of ADAS, and a subscale of FAQ) and a demographic data (patient’s age) as input yielded high AUC scores. Some of these authors deepened in their previous works with CPNs and tested this neural network even more [ 118 ]. A similarly high performance was achieved with different scales and demographic data: the total scores of FAQ, MMSE, and GDS, age and years of education.…”

A systematic review of clinical health conditions predicted by machine learning diagnostic and prognostic models trained or validated using real-world primary health care data

“…In 22 studies of this ICD-10 classifications addressing six health conditions [28,45,[89][90][91][92][93][94][95][96][97]119,81,120,121,[82][83][84][85][86][87][88], the involved population were from eight countries, mainly the US and the UK (n=14). These studies were published since 2013 with the highest number of studies in 2020 (44.4%).…”

A Study on the Correlation Between Age-Related Macular Degeneration and Alzheimer's Disease Based on the Application of Artificial Neural Network

“…Some studies have found that AMD and AD are not only common in epidemiology, but also common in molecular aspects ( 19 ). For example, the characteristic senile plaque of AD and the marker drusen of AMD have common active ingredients, the most important of which is Aβ, both of which contain and ( 20 ).…”